AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...
Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has ...
Throughout his Ph.D. research, Narechania held fast to the belief that human decisions are best guided by data. Better data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback